Roche RHHBY announced that the European Medicines Agency has approved a prefilled syringe (PFS) of the ophthalmology drug Vabysmo (faricimab). The regulatory body approved Vabysmo PFS for use in the ...
Roche (RHHBY) announced that the European Medicines Agency, EMA, has approved Vabysmo 6.0 mg single-dose prefilled syringe, PFS, for use in the treatment of neovascular or ‘wet’ age-related macular ...